This page lists the surgical gastroenterology hospitals in our directory offering Pancreatic Cancer Treatment in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.
Ask us about pancreatic cancer treatment in Delhi NCR, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 35 accredited hospitals for Surgical Gastroenterology in Delhi NCR, India
🇮🇳 Apollo Hospitals
🇮🇳 Medanta - The Medicity
🇮🇳 Artemis Hospital
🇮🇳 Fortis Memorial Research Institute
🇮🇳 Max Super Specialty Hospital
🇮🇳 All India Institute of Medical Sciences (AIIMS)
🇮🇳 CK Birla Hospital
🇮🇳 Centre for Sight
🇮🇳 Max Super Specialty Hospital, Gurgaon
🇮🇳 Max Super Speciality Hospital, Patparganj
🇮🇳 Primus Super Speciality Hospital
🇮🇳 PSRI Multispeciality Hospital
🇮🇳 Fortis Hospital, Shalimar Bagh
🇮🇳 Sarvodaya Hospital
🇮🇳 Indian Spinal Injuries Center
🇮🇳 Max Super Speciality Hospital, Shalimar Bagh
🇮🇳 Fortis Hospital, Noida
🇮🇳 Venkateshwar Hospital
🇮🇳 CK Birla Hospital
🇮🇳 Fortis Flt. Lt. Rajan Dhall Hospital
🇮🇳 Asian Institute of Medical Sciences
🇮🇳 Manipal Hospitals Dwarka
🇮🇳 Sir Ganga Ram Hospital
🇮🇳 Fortis Escorts Hospital
🇮🇳 Marengo Asia Hospitals
🇮🇳 Yatharth Super Specialty Hospital
🇮🇳 Paras Hospitals
🇮🇳 Fortis Hospital Manesar
🇮🇳 Marengo Asia Hospitals Gurgaon
🇮🇳 Metro Hospital Noida
🇮🇳 Sharda Hospital
🇮🇳 Fortis Hospital, Greater Noida
🇮🇳 Fortis Escorts Hospital Jaipur
🇮🇳 Max Super Speciality Hospital, Saket
🇮🇳 BLK-Max Super Speciality Hospital
How we selected these hospitals
A hospital appears on this page when Surgical Gastroenterology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Pancreatic Cancer Treatment in Delhi NCR, India?
Choosing the right hospital for pancreatic cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include surgical gastroenterology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Pancreatic Cancer Treatment
Pancreatic cancer treatment encompasses a spectrum of interventions — from curative-intent Whipple procedures and distal pancreatectomies to advanced systemic therapies including FOLFIRINOX, gemcitabine-nab-paclitaxel combinations, and precision-targeted PARP inhibitors for BRCA-mutated tumors. Resection in high-volume centers achieves 5-year survival rates of 20–25% for Stage I–II disease, while multimodal protocols for locally advanced cases continue to improve median overall survival. GAF Healthcare connects international patients with JCI- and NABH-accredited oncology centers in India and JCI- and DHA-licensed cancer hospitals in Dubai and Abu Dhabi, offering world-class surgical and oncologic expertise at a fraction of Western costs, with full end-to-end logistical support.
Clinical Overview
Pancreatic cancer — most commonly pancreatic ductal adenocarcinoma (PDAC) — arises from the exocrine cells lining the pancreatic ducts and accounts for approximately 90% of all pancreatic malignancies. Because the pancreas is a deeply retroperitoneal organ with rich lymphovascular proximity to the superior mesenteric artery (SMA), portal vein, and celiac axis, early-stage disease is largely asymptomatic, resulting in over 80% of cases being diagnosed at locally advanced (Stage III) or metastatic (Stage IV) stages. Physiologically, tumor involvement disrupts both exocrine function — leading to malabsorption, steatorrhea, and significant weight loss — and endocrine function, frequently inducing new-onset diabetes mellitus. Obstructive jaundice due to common bile duct compression is a hallmark presentation in pancreatic head tumors and is managed with endoscopic retrograde cholangiopancreatography (ERCP) stenting prior to definitive surgery.
Full details →Who is a Candidate?
- ELIGIBLE FOR SURGICAL RESECTION (Whipple / Distal Pancreatectomy / Total Pancreatectomy):
- Pathologically or radiologically confirmed pancreatic ductal adenocarcinoma, acinar cell carcinoma, or pancreatic neuroendocrine tumor (pNET)
- Radiologically resectable disease: no arterial abutment of SMA, celiac axis, or hepatic artery; no venous occlusion of SMV/portal vein beyond reconstructable limits
Full details →Treatment Options & Approaches
Surgical APPROACHES:
1. Pancreaticoduodenectomy (Whipple Procedure) — Standard & Pylorus-Preserving (PPPD):
The gold-standard curative resection for pancreatic head and uncinate process tumors. En bloc removal of the pancreatic head, duodenum, proximal jejunum, gallbladder, and common bile duct, with reconstruction via pancreaticojejunostomy, hepaticojejunostomy, and gastro/duodenojejunostomy. The pylorus-preserving modification (PPPD) maintains the stomach and pylorus, reducing post-gastrectomy complications while maintaining oncologic equivalence. Vascular resection and reconstruction of the SMV/portal vein axis (segmental resection with primary anastomosis or interposition graft) is performed in borderline resectable cases at high-volume centers.
2. Distal Pancreatectomy with Splenectomy (DP-CAM for left-sided tumors):
Full details →Recovery
PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (Weeks 1–2):
- Patient submits medical records (pathology report, imaging DICOM files, prior treatment summaries) to GAF Healthcare's medical team
- GAF Healthcare oncology coordinators arrange a virtual multidisciplinary tumor board (MDT) review with the treating surgeon, medical oncologist, and interventional radiologist at the selected partner hospital
- Treatment plan confirmed: surgery vs. neoadjuvant chemotherapy first vs. systemic therapy
- GAF Healthcare initiates e-Medical Visa application (India) or UAE entry visa facilitation
- Pre-travel fitness assessment: cardiology clearance, nutritional optimization, glycemic control for diabetic patients
- Arrangements: airport transfer, hospital-adjacent accommodation for 1–2 attendants
PHASE 2 — ARRIVAL & PRE-OPERATIVE WORKUP (Days 1–3 in-country):
Full details →Risks to be aware of
Pancreatic cancer treatment carries a meaningful spectrum of procedural and oncologic risks that patients must understand transparently. For the Whipple procedure (pancreaticoduodenectomy), the most clinically significant complication is Post-Operative Pancreatic Fistula (POPF), occurring in 10–25% of cases and classified Grade A (biochemical leak), B (requiring intervention), or C (life-threatening) per ISGPS criteria; Grade B/C fistulas may require percutaneous drain insertion, radiologic intervention, or re-operation. Delayed Gastric Emptying (DGE) affects 20–30% of patients, prolonging hospital stay by 5–10 days on average and requiring nutritional support via nasojejunal feeding. Post-pancreatectomy haemorrhage (PPH) is rare (<5%) but potentially life-threatening, with sentinel bleed from the gastroduodenal artery stump being a recognized early warning. Bile leak occurs in approximately 5–10% of cases and is managed with ERCP stenting or percutaneous drainage in most instances. Total pancreatectomy mandates lifelong insulin-dependent diabetes management and carries risks of severe brittle hypoglycemia, necessitating experienced endocrinology support. General surgical risks include wound infection (10–15%), pulmonary complications including pneumonia and atelectasis (10%), deep vein thrombosis and pulmonary embolism (3–5% despite prophylaxis), and anastomotic stricture requiring late endoscopic intervention. For systemic chemotherapy, FOLFIRINOX carries significant cumulative neurotoxicity (peripheral neuropathy in >50% of patients), myelosuppression with febrile neutropenia risk (5–10%), and severe diarrhea and fatigue; dose modifications are routine. Gemcitabine-nab-paclitaxel carries risks of peripheral neuropathy, myelosuppression, and alopecia. PARP inhibitors (olaparib) are associated with anemia, nausea, and rare pneumonitis. Oncologically, even after R0 resection, the 5-year overall survival remains 20–25% for Stage I–II disease, and patients must be counseled about the high recurrence risk (70–80% within 2 years), most commonly to the liver and peritoneum. At GAF Healthcare partner hospitals, all patients undergo pre-operative MDT review, intraoperative frozen section margin analysis, and post-operative care within ERAS protocols, which collectively reduce major complication rates and improve recovery benchmarks compared to non-specialized centers.
Why GAF Healthcare
GAF Healthcare provides comprehensive, white-glove medical travel coordination for international patients pursuing pancreatic cancer treatment in India or the UAE, covering every logistical need from first inquiry to departure.
Common questions about Pancreatic Cancer Treatment
What is the cost of Pancreatic Cancer Treatment in India vs. the UAE?
How long do I need to stay in the country before I am fit to fly home after Pancreatic Cancer Treatment?
What is the success rate of Pancreatic Cancer Treatment?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Pancreatic Cancer Treatment in Delhi NCR, India
Discover the Top Hospitals for Pancreatic Cancer Treatment in Delhi NCR, India
This page lists 35 accredited surgical gastroenterology hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about pancreatic cancer treatment in Delhi NCR, India
How many surgical gastroenterology hospitals are listed in Delhi NCR, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there surgical gastroenterology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for pancreatic cancer treatment in Delhi NCR, India.
Contact us to report an inaccuracy on this page.